MEDecision Names Andrew P. Schuyler Executive Vice President and Chief Medical Officer
21 4월 2008 - 9:30PM
Business Wire
MEDecision, Inc. (Nasdaq: MEDE), a leading provider of
collaborative health care management solutions, today announced
that it has named Andrew P. Schuyler, M.D. Executive Vice President
and Chief Medical Officer (CMO). Dr. Schuyler joins MEDecision from
Horizon Blue Cross Blue Shield (BCBS) of New Jersey, where he was
executive medical director. As CMO, Dr. Schuyler will be
responsible for overseeing MEDecision�s clinical leadership and
excellence. He will work with other members of the company�s
clinical staff to extend MEDecision�s strong position in
collaborative health care management as it continues its shift from
product development to execution and customer satisfaction. �Dr.
Schuyler�s vast experience and expertise make him an ideal fit for
this position and will enable him to continue growing MEDecision�s
clinical initiatives,� said David St.Clair, Founder and CEO of
MEDecision. �We�re very pleased to have someone with his
credentials in this important role as we increase our emphasis on
clinical excellence and meeting the health care management needs of
our customers.� �This is a very exciting time for MEDecision,� said
Dr. Schuyler. �With its new products, Alineo and Nexalign, the
company is perfectly positioned to take advantage of the rapidly
expanding collaborative health care market. I�m very enthused to be
a part of the team that helps MEDecision realize this tremendous
potential.� Later today, Dr. Schuyler will conduct a Market Insight
presentation at the 5th Annual World Health Care Congress in
Washington, D.C. The discussion, titled �The Use of Patient
Clinical Information to Affect Care,� will take place at 3:55 p.m.
EDT at the Marriott Wardman Park Hotel. Dr. Schuyler served in an
executive capacity at Horizon BCBS since August 2004. He was
responsible for concurrent medical management, medical policy,
appeals and process redesign and development of integrated medical
management. Prior to joining Horizon, Dr. Schuyler spent 17 years
in managed care administration, including time with the former U.S.
Healthcare and Aetna, last serving in the role of senior medical
director. His earlier clinical and academic experience includes six
years as associate director of a family practice residency training
program affiliated with the University of Medicine and Dentistry of
New Jersey, and four years in the private practice of family
medicine. Dr. Schuyler completed his undergraduate studies at
Williams College. He earned his medical degree from Cornell
University Medical College and completed a combined Family Medicine
and Psychiatry residency/fellowship at Columbia College of
Physicians and Surgeons. For more information about MEDecision,
please visit www.MEDecision.com. About MEDecision MEDecision offers
collaborative health care management solutions that provide a
simplified and smart way to manage the health of members and member
populations which can improve the quality and affordability of
care. Based on state-of-the-art technology, MEDecision�s solutions
include Alineo�, a collaborative health care management platform
for managing case, disease and utilization management and
Nexalign�, a collaborative health care information exchange
service. MEDecision believes that, in the aggregate, its health
care payer customers insure or manage care for approximately one in
every six people in the U.S. with health insurance. For more
information, please visit www.MEDecision.com. MEDecision is a
trademark of MEDecision, Inc. The MEDecision logo and product names
are also trademarks or registered trademarks of MEDecision, Inc.
Other product and brand names are trademarks of their respective
owners. MEDE-G
Medecision (MM) (NASDAQ:MEDE)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Medecision (MM) (NASDAQ:MEDE)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Medecision (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More MEDecision, Inc. News Articles